Navigation Links
United BioSource Scientists, FDA, and Other Industry Leaders Present to Risk Management and Drug Safety Summit
Date:11/19/2008

Conference: How to Build Effective Global Programs Required by New Legislation

BETHESDA, Md., Nov. 19 /PRNewswire/ -- United BioSource Corporation's (UBC) Annette Stemhagen, DrPH, FISPE, and Gerald Faich, MD, MPH, FISPE, addressed the Risk Management and Drug Safety Summit held in Washington, DC, on October 28 and 29, along with Janet Woodcock, MD, Director, CDER, FDA; Jane Axelrad, Associate Director for Policy, CDER, FDA; Claudia Karwoski, acting director, Division of Risk Management Team, Office of Surveillance and Epidemiology, CDER; and other leading scientists from the pharmaceutical community.

(LOGO: http://www.newscom.com/cgi-bin/prnh/20070910/NEM007LOGO)

Co-sponsored by UBC and FDA News, the two-day conference was designed to help drug and biologics manufacturers understand how to build effective global risk management and drug safety programs, in response to the FDA Amendments Act of 2007 (FDAAA) and new international regulations now under development.

Patrick Lindsay, UBC's Executive Vice President, said "UBC was pleased to join forces with FDA News to bring together this esteemed group of experts in risk management. We recognize how important it is to master the critical components of the FDAAA to optimize pharmaceutical products, both for the safety of patients and to create value for pharma and biotech companies."

Dr. Stemhagen, Vice President, Epidemiology and Risk Management, UBC, spoke about "Using Registries and Large Streamlined Studies (LSS) to Improve Post-Approval Safety Surveillance, Risk Assessment and Risk Management," reviewing key factors to consider before implementing a registry or LSSs, best practices for using registries as part of risk management planning, and real-world case studies using LSSs.

Dr. Faich, Senior Vice President, Epidemiology and Risk Management, UBC, co-moderated a session called "How Does the FDA Intend to Evaluate REMS (Risk Evaluation Mitigation Strategy)?" with Dr. Stemhagen and other industry leaders. This session evaluated how FDA's response to previously submitted REMS provides insight into how to create successful and compliant REMS.

Other speakers included:

  • Laurent Auclert, MD, Head, Risk Management Plan Unit, Global Pharmacovigilance & Epidemiology, sanofi-aventis

  • Cherif Benatti, MD, Vice President, Pharmacovigilance & Public Health, Vertex Pharmaceuticals

  • Carmen Bozic, Vice President, Drug Safety & Risk Management, Biogen Idec

  • John Ferguson, Vice President & Global Head, Pharmacovigilance & Medical Safety, Novartis Vaccines & Diagnostics

  • Joanna Haas, MD, MS, Vice President, Pharmacovigilance, Genzyme Corporation

  • Peter Pitts, Co-founder and President of Center for Medicine in the Public Interest and Senior Vice President, Health Affairs, Manning, Selvage & Lee

  • Donald Therasse, MD, Vice President, Global Patient Safety, Lilly Research Laboratories

"All conference presenters were mindful of the pressure on drug and biologics manufacturers in light of FDAAA's passage in late March 2007," noted Dr. Stemhagen. "Since then, FDA has mandated REMS for 31% of all new molecular entities and novel therapeutic biologics. In just the past seven months, we at UBC have seen a dramatic increase in the number of clients who have asked us to assist with REMS."

United BioSource Corporation (UBC) is a global pharmaceutical services organization that helps emerging and established life science companies develop and commercialize medical products. UBC specializes in offering new and innovative ways to study drugs and devices by providing expertise in science, strategy and execution.

UBC is headquartered in Bethesda, Maryland, with offices in the United States, Canada, Western Europe, Eastern Europe and South America. For more information, visit www.unitedbiosource.com or call 866-458-1096.

CONTACT: Tess Drahzal, +1 (240) 644-0420, info@unitedbiosource.com


'/>"/>
SOURCE United BioSource Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress
2. United States continues to have highest level of health spending
3. United Medicorp, Inc.s Shareholders Approve All Proposals
4. Proven Terumo Coronary Guidewire Technology Is Now Available in the United States
5. Medical Services International Received Its First Order for Testing By Regulatory Agencies in the United States
6. Peoples United Financial CEO Has Surgery
7. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
8. More Than 100 Organizations Call for a National AIDS Strategy to End the Epidemic in the United States
9. Akers Biosciences, Inc. ABI or the Company Receipt of Further United States Military Contracts
10. Universal Health Care Coverage in the United States
11. Women Deliver Conference to Feature United Nations Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at ... of the most popular and least understood books in the Holy Scriptures, Revelation. The ... that have baffled scholars for centuries. Many have tossed it off as mere rubbish, ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... healthcare compliance program management, will showcase a range of technology and learning solutions ... Living (NCAL) Convention and Expo to be held October 14–18, 2017 at the ...
(Date:10/12/2017)... , ... October 12, 2017 , ... The American College ... to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in ... , In honor of Morris F. Collen, a pioneer in the field of medical ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... D.C., for the 49th Congress of the International Society of Paediatric Oncology ... the Center for Cancer and Blood Disorders at Children’s National, and Stephen ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... the latest in wound care advancements to physician colleagues, skilled nursing facility medical ... titled, "Navigating the Treacherous Waters of Wound Care." , "At many of these ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... , Oct. 12, 2017 West ... in innovative solutions for injectable drug administration, today announced ... the market opens on Thursday, October 26, 2017, and ... results and business expectations at 9:00 a.m. Eastern Time. ... or 253-336-8738 (International). The conference ID is 94093362. ...
(Date:10/11/2017)... 11, 2017  True Health, a leader in ... effort during National Breast Cancer Awareness month to ... Research recently ... that more than 10 million American women are ... BRCA1 or BRCA2 and have not had testing. These ...
(Date:10/10/2017)... 2017   West Pharmaceutical Services, Inc. (NYSE: ... drug administration, today shared the results of a study ... the intradermal administration of polio vaccines. The study results ... May 2017 by Dr. Ondrej Mach , Clinical ... Organization (WHO), and recently published in the journal ...
Breaking Medicine Technology: